Navigation Links
Lupin Announces Litigation Settlement with Schering-Plough Corporation for Desloratadine(R)
Date:12/17/2008

MUMBAI, India, Dec. 17 /PRNewswire/ -- Pharma Major, Lupin Ltd. announced today that it has settled all ongoing Hatch-Waxman litigation relating to Desloratadine tablets, the generic version of Schering-Plough's "Clarinex"(R) tablets.

As per the terms of the settlement, Lupin Ltd. will be licensed under the relevant Desloratadine patents, and free to commercially launch its generic Desloratadine product, on July 1, 2012, or earlier in certain circumstances.

Lupin had earlier filed a Paragraph IV certification to, among others, U.S. Patent Nos. 6,100,274, 7,214,683 and 7,214,684, contesting that these patents were either invalid or had not been infringed upon - resulting in the subsequent litigation by Schering Corp. and Sepracor.

Schering-Plough's Clarinex(R) tablets had U.S. sales of $329 million for the year 2007-MAT June 2008, according to IMS Health.

Commenting on the settlement, Dr. Kamal Sharma, Managing Director, Lupin said - "The settlement with Schering-Plough leaves us strategically poised to further strengthen, consolidate and grow our market position in the U.S. markets. Furthermore, the settlement, recent product approvals and growth in filings across markets are a testament to our increased strengths and focus on Research & Development and the quality of our Intellectual property - a testimony to Lupin's larger goal of developing and delivering quality, cost-effective drugs for everybody."

About Lupin

Headquartered in Mumbai, India, Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs for the developed and developing markets of the world. The Company has secured global leadership position in Anti-TB and Cephalosporins and has a significant presence in the areas of Cardiovasculars (prils and statins), Diabeto
'/>"/>

SOURCE Lupin Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc. for AeroChamber Plus(R) Brand in the US - Extends its Franchise with Pediatricians
2. Lupin Receives USFDA Approval for Divalproex Sodium Delayed-Release Tablets
3. Lupin Enters Into Marketing Alliance with ASCEND Therapeutics for Suprax(R) 400 mg Tablets in the U.S.
4. Lupin Receives USFDA Approval for Escitalopram Oxalate Tablets
5. Lupin Launches Ramipril Capsules
6. Lupin Receives USFDA Approval for Topiramate Tablets
7. Dynatronics Announces Changes to Board and Launches Operational Improvement Process
8. SantaFe Senior Living Announces Leadership Transition
9. Elsevier announces new partnership between the Journal of Pain and Symptom Management and the AAHPM
10. Finesse Announces TruDO Optical Autoclavable Sensors for Bioprocess Applications
11. Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... ... benefit Core Compassion Project. Core Compassion Project is a non-profit organization dedicated ... reduce the side effects of cancer treatments and recover their mobility, strength, and ...
(Date:9/4/2015)... ... September 04, 2015 , ... San Francisco ... at CitiDent. CEREC is a newer method for creating restorations through innovative imaging ... by eliminating the need for multiple appointments, CEREC produces restorations with total precision ...
(Date:9/4/2015)... PA (PRWEB) , ... September 04, 2015 , ... Many consumers are looking for a ... could be their solution. , The patent-pending K Med Cups provide a quick and simple ... help to relieve a cold, flu or cough. As a result, they enhance comfort and ...
(Date:9/4/2015)... ... September 04, 2015 , ... The conference program for the ... October 9-10, 2015 at the Diplomat Resort & Spa has been announced and ... researchers at the top of their field and will be presenting sessions such ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... Lalonde Gordon ... heat, and followed up with victory in the men’s 400 meters final, with an ... Track and Field Championships in San Jose, Costa Rica in August 2015. The 44.64 ...
Breaking Medicine News(10 mins):Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3
... The battle against HIV/AIDS is becoming grimmer by the day. ... could be infected with HIV/AIDS by 2015 if the ... ,"We should be winning in HIV prevention," Jennifer Kates, ... Family Foundation, said Friday. ,But the reality is ...
... researchers suggests that proteins that cause mad cow disease ... ,In laboratory tests, the researchers observed that high ... accumulation of beta amyloid, the building blocks of Alzheimer's ... says that the findings, published in the Proceedings of ...
... from Saturday to move forward the global tobacco control agenda ... Parties to the WHO Framework Convention on Tobacco Control (WHO ... June 30 to July 6 2007 in the United Nations ... meeting will help countries to strengthen their tobacco control programs ...
... quit smoking? Get a national TV network to publicize your ... study that found calls to a national smoking-cessation hotline more ... death from lung cancer. ,Its not enough just ... advertise it, said Erik Augustson, a behavioral scientist with the ...
... on to list Taj Mahal in the new Seven Wonders ... haze of dust and smog. ,,Environmentalists and historians, ... gleaming white Taj Mahal black, have raised an alarm for ... University, says the Taj needs corrective treatment fast."We have to ...
... and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that ... tablets has been submitted to the U.S. Food ... with hepatocellular carcinoma (HCC), the most common form of ... more than 50 countries for the treatment of advanced ...
Cached Medicine News:Health News:Expand HIV/AIDS Prevention Programs, Experts Stress 2Health News:Expand HIV/AIDS Prevention Programs, Experts Stress 3Health News:Proteins Behind Mad Cow Disease may Protect Against Alzheimer's 2Health News:WHO to Call for More Progress on Tobacco Control at Bangkok Moot 2Health News:National TV Promotion Triples Calls to Smoking Cessation Hotline 2Health News:Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer 2
(Date:9/3/2015)... Sept. 3,  2015 About artificial ... devices, which are implanted or integrated into ... These include artificial heart, kidney, pancreas, and ... (polyurethane, polysulfone, and porous polypropylene), biologics, ceramics, ... organs. These organs are incorporated with different ...
(Date:9/3/2015)... 3, 2015 This Defibrillators are critical life ... of lives across globe. This report provides in-depth analysis ... Saudi Arabia . Stakeholders for this report include ... and regulatory bodies. The Saudi Arabia ... by products and by end users. In terms of ...
(Date:9/3/2015)... 3, 2015 Nevro Corp. (NYSE: NVRO ... innovative evidence-based solutions for the treatment of chronic pain, ... the Morgan Stanley Global Healthcare Conference on Thursday, September ... Nevro management is scheduled to present at 11:45 a.m. ... audio webcast, accessible in the "Investors" section of the ...
Breaking Medicine Technology:Global Artificial Organ Market 2015-2019 2Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2
... LAGUNA HILLS, Calif., Sept. 30 Minnow Medical, Inc., ... thermoplasty for the treatment of in-stent restenosis and other ... executive Raymond W. Cohen has been named chief executive ... Cohen, 51, has more than 25 ...
... Ohio, Sept. 30 Although last year,s flu season ... illness and associated vaccine shortages, pharmacy experts at Cardinal ... for the 2010-2011 flu season. The upcoming ... federal government,s Advisory Committee on Immunization Practices (ACIP) has ...
Cached Medicine Technology:Minnow Medical Names Raymond W. Cohen as Chief Executive Officer 2Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 2Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 3Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: